<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
60422-220-01
</NDCCode>
<PackageDescription>
1 SYRINGE, GLASS in 1 BOX (60422-220-01) / .9 mL in 1 SYRINGE, GLASS
</PackageDescription>
<NDC11Code>
60422-0220-01
</NDC11Code>
<ProductNDC>
60422-220
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Tocilizumab
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20131021
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Chugai Pharmaceutical Co., Ltd.
</LabelerName>
<SubstanceName>
TOCILIZUMAB
</SubstanceName>
<StrengthNumber>
162
</StrengthNumber>
<StrengthUnit>
mg/.9mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-02-24
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
21-OCT-13
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>